- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/28 - Insulins
Patent holdings for IPC class A61K 38/28
Total number of patents in this class: 2548
10-year publication summary
270
|
232
|
213
|
242
|
259
|
244
|
215
|
190
|
169
|
51
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novo Nordisk A/S | 2324 |
127 |
MannKind Corporation | 531 |
110 |
Eli Lilly and Company | 3645 |
63 |
Adocia | 143 |
62 |
Case Western Reserve University | 1727 |
54 |
Rani Therapeutics, LLC | 184 |
53 |
Hanmi Pharm. Co., Ltd. | 546 |
48 |
Sanofi-Aventis Deutschland GmbH | 2738 |
47 |
Sanofi | 3836 |
37 |
Merck Sharp & Dohme LLC | 3689 |
32 |
Medtronic MiniMed, Inc. | 1808 |
26 |
Merck Sharp & Dohme Corp. | 2247 |
25 |
North Carolina State University | 1492 |
25 |
Insulet Corporation | 736 |
24 |
SDG, Inc. | 32 |
23 |
Massachusetts Institute of Technology | 9795 |
22 |
Halozyme, Inc. | 120 |
22 |
Indiana University Research and Technology Corporation | 808 |
22 |
Boehringer Ingelheim International GmbH | 4629 |
20 |
Arecor Limited | 100 |
20 |
Other owners | 1686 |